Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von OldOrangeEyes 

AstraZeneca plc diskutieren

AstraZeneca plc

WKN: 886455 / Symbol: AZNCF / Name: AstraZeneca / Aktie / Pharmazeutika / Large Cap /

119,90 €
0,17 %

Buy AstraZeneca plc

Buy AstraZeneca plc

Buy AstraZeneca plc

Einschätzung Buy
Rendite (%) 28,85 %
Kursziel 62,35
Veränderung
Endet am 10.03.22

Considering AZN's strong performance and the estimated growth of the sector due to COVID-19, we issue a buy recommendation.

Sell AstraZeneca plc

Einschätzung Buy
Rendite (%) 1,35 %
Kursziel 135,50
Veränderung
Endet am 12.11.25

Look, I know the news about AstraZeneca's exec being detained in China sounds scary. It's like finding a fly in your soup - unsettling, right? But here's the thing: AstraZeneca's a big player in the pharma world, and they've weathered storms before. This China situation? It's a bump in the road, not a roadblock. The company's fundamentals are solid, and they're at the forefront of some exciting medical breakthroughs. Plus, their current price feels like a bargain - it's like finding a designer coat on the clearance rack. Sure, there's some risk, but isn't that true for any investment? I think AstraZeneca's got the potential to bounce back stronger than ever. It's not all smooth sailing, but hey, who doesn't love a good comeback story?

Einschätzung Buy
Rendite (%) -14,27 %
Kursziel 155,50
Veränderung
Endet am 11.02.26

Hey there! I've been keeping a close eye on AstraZeneca, and I've got to say, I'm pretty bullish on this one. Their recent earnings report was like a shot in the arm - total revenue up 21% for the year? That's nothing to sneeze at! Sure, there's some headwinds with the China investigations, but the company seems to be handling it well. They're expecting a fine of up to $4.5 million, which is honestly just a drop in the bucket for a pharma giant like AZN. What really gets me excited is their pipeline - nine high-value pivotal trials on the horizon, and they're aiming for 20 new medicines by 2030. Talk about ambition! Plus, that dividend increase to $3.10 per share? It's like they're sharing the wealth with us investors. The way I see it, AstraZeneca is like a well-oiled machine that's not just running smoothly, but picking up speed. With their strong growth across all therapy areas and key geographies, I think they're well-positioned to weather any storms and come out stronger. What do you think - ready to hop on this rocket ship?